Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$17.6K
19.09K shares
What this filing means
DIBIASE MARY plans to sell 19.09K shares of X4 PHARMACEUTICALS, INC valued at approximately $17.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2024ACC: 0001973141-24-000167
Officer· Chief Operating Officer
Since Sep 2021
19.09K
Shares to sell
$17.6K
Approx. market value
15.41K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Award
NA
3/11/2024
15.41KTotal acquired15.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2024 | Stock Award NA | 15.41K | — |
| Total | 15.41K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.68K
Market value
$3.7K
2/12/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
15.41K
Market value
$13.9K
3/11/2024
Total
Units
19.09K
Value
$17.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/12/2024 | 3.68K | $3.7K | — | Completed |
| Planned — Approximate Date | ||||
3/11/2024 | 15.41K | $13.9K | NASDAQ | Planned |
| Total | 19.09K | $17.6K | ||